Kawasaki disease: diagnosis, management and cardiac sequelae (Q28210070)

Expert Review of Cardiovascular Therapy

Europe PubMed Central

title

Kawasaki disease: diagnosis, management and cardiac sequelae (English)

0 references

1 reference

Louise Wood

1

0 references

Robert Tulloh

series ordinal

2

0 references

language of work or name

English

0 references

publication date

May 2007

0 references

published in

0 references

volume

5

0 references

issue

3

0 references

page(s)

553-61

0 references

cites work

Kawasaki disease: A brief history.

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Kawasaki disease: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Cardiac sequelae of Kawasaki disease among recurrent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

An update on Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Kawasaki disease: what is the epidemiology telling us about the etiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Association between a novel human coronavirus and Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Current perspectives on Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Kawasaki disease and human coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Lack of association between New Haven coronavirus and Kawasaki disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Update on the treatment of Kawasaki disease in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Incidence and clinical features of incomplete Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Kawasaki disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Novel therapies in vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Behaviour sequelae following acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Dilated coronary arterial lesions in the late period after Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 863 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Dobutamine stress echocardiography in the evaluation of young patients with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Myocardial blood flow and coronary flow reserve in children with "normal" epicardial coronary arteries after the onset of Kawasaki disease assessed by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Altered myocardial flow reserve and endothelial function late after Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Poor agreement between dipyridamole-stress technetium-99m-tetrofosmin myocardial perfusion single photon emission computed tomography and two-dimensional echocardiography in Kawasaki disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Transthoracic Doppler assessment of coronary flow velocity reserve in children with Kawasaki disease: comparison with coronary angiography and thallium-201 imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Non-invasive measurement of coronary flow reserve in children with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Coronary flow reserve assessment by Doppler echocardiography in children with and without congenital heart defect: comparison with invasive technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Coronary MR angiography clinical applications and potential for imaging coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553

Antioxidants may mitigate the deterioration of coronary arteritis in patients with Kawasaki disease unresponsive to high-dose intravenous gamma-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14779072.5.3.553